Clinical Trial Update: Corneal Crosslinking Treatment Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating corneal crosslinking for progressive keratoconus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Snippet

Sponsor: Region Skane | Conditions: Progressive Keratoconus | Phase 4 | Status: COMPLETED